Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 6.99M | $15M | $2.15 | Jan 19, 2024 | By Velan Capital Master Fund LP |
HERON THERAPEUTICS, INC. /DE/ | Director | Stock Option (Right to Buy) | 83.7K | $149K | $1.78 | Jan 19, 2024 | Direct |
HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 51.8K | $111K | $2.15 | Jan 19, 2024 | Direct |
ALIMERA SCIENCES INC | Director, 10%+ Owner | Common Stock | 0 | $0 | $3.83 | Sep 16, 2024 | By Velan Capital Master Fund LP |
ALIMERA SCIENCES INC | Director, 10%+ Owner | Common Stock | 0 | $0 | $3.83 | Sep 16, 2024 | By Velan Capital SPV I LLC |
HERON THERAPEUTICS, INC. /DE/ | Director | Pre-funded Warrants to Purchase Common Stock | 1.16M | Jul 21, 2023 | By Velan Capital Master Fund LP | ||
ALIMERA SCIENCES INC | Director, 10%+ Owner | Stock Option (Right to Buy) | 0 | Sep 16, 2024 | Direct | ||
ALIMERA SCIENCES INC | Director, 10%+ Owner | Warrants | 0 | Sep 16, 2024 | By Velan Capital Master Fund LP |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALIM | ALIMERA SCIENCES INC | Sep 16, 2024 | 5 | $0 | 4 | Sep 16, 2024 | Director, 10%+ Owner |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Jan 19, 2024 | 2 | $0 | 4 | Jan 19, 2024 | Director |
ALIM | ALIMERA SCIENCES INC | Oct 2, 2023 | 1 | $0 | 4 | Oct 4, 2023 | Director, 10%+ Owner |
ALIM | ALIMERA SCIENCES INC | Aug 15, 2023 | 6 | $21.5M | 4 | Aug 17, 2023 | Director, 10%+ Owner |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Jul 21, 2023 | 2 | $5M | 4 | Jul 25, 2023 | Director |
ALIM | ALIMERA SCIENCES INC | May 17, 2023 | 4 | $2.38M | 4 | May 19, 2023 | Director, 10%+ Owner |
ALIM | ALIMERA SCIENCES INC | Mar 26, 2023 | 1 | $0 | 4 | Mar 28, 2023 | Director |
ALIM | ALIMERA SCIENCES INC | Mar 24, 2023 | 0 | $0 | 3 | Mar 28, 2023 | Director |
HRTX | HERON THERAPEUTICS, INC. /DE/ | Feb 22, 2023 | 2 | $0 | 4 | Feb 24, 2023 | Director, Other* |